Navamedic ASA announced the launch of four branded generic pharmaceuticals. The new products are initially introduced in the Dutch and Belgian markets. The four generic drugs now being launched are: Eltroxin-treatment of patients with various thyroid deficiencies.

Lanoxin-treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Imuran- an immunosuppressive drug used in organ transplants and autoimmune diseases. Zyloric-treatment of excess uric acid in the blood and complications caused by this, including chronic gout.